We demonstrate in a cohort of primarily hospitalized patients with acute COVID-19 that there is increased complement deposition on the cell surface of monocytes with a possibly compensatory upregulation of the CD55 complement inhibitor. The gene discussed is CD55; the disease is COVID-19.